Pharming (PHAR) Change in Cash (2019 - 2025)
Pharming's (PHAR) quarterly Change in Cash came in at $11.7 million in Q4 2025, up 354.94% YoY from $2.6 million in Q4 2024, and up 354.94% on a QoQ basis from -$4.6 million in Q4 2024.
Pharming (PHAR) Change in Cash (2019 - 2025) Analysis & Trends
Pharming (PHAR) has 7 years of Change in Cash data on file, last reported at $11.7 million in Q4 2025.
- Quarterly Change in Cash rose 354.94% year-over-year to $11.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$128.0 million (up 32.34% YoY) and the FY2025 annual result came in at $82.5 million, up 1896.77% from the prior year.
- Change in Cash improved to $11.7 million in Q4 2025, from -$4.6 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $12.7 million in Q3 2024 to a low of -$147.7 million in Q4 2023.
- A 5-year average of -$27.7 million and a median of -$3.6 million in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2021 — Change in Cash surged 1475.81% — and 2023, when it tumbled 5464.18%.
- Tracing PHAR's Change in Cash over 5 years: stood at $2.1 million in 2021, then plunged by 225.47% to -$2.7 million in 2022, then plunged by 5464.18% to -$147.7 million in 2023, then soared by 96.89% to -$4.6 million in 2024, then soared by 354.94% to $11.7 million in 2025.
- The last three Change in Cash figures came in at $11.7 million (Q4 2025), -$4.6 million (Q4 2024), and $12.7 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | -4.59 Mn |
| Sep 30, 2024 | 12.66 Mn |
| Dec 31, 2023 | -147.73 Mn |
| Sep 30, 2023 | -49.46 Mn |
| Jun 30, 2023 | -104.92 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Sep 30, 2022 | 10.40 Mn |
| Dec 31, 2021 | 2.12 Mn |
| Sep 30, 2021 | -4.72 Mn |
| Dec 31, 2020 | 134,280.45 |
| Sep 30, 2020 | 13.95 Mn |
| Dec 31, 2019 | -17.00 Mn |